#Adrenergic Drugs {#id}

Adrenergic drugs are sympathomimetic based on a **benzene ring**, with different amine side chains. When a hydroylgroup is present at the C3 and C4 positions, it is known as a **catecholamine**. All adrenergic act via either a dopamine (D) or adrenoreceptors (α and β). **Direct-acting** stimulate the receptor, whilst **indirect-acting** release noradrenaline to cause sympathomimetic effects.

##Receptor types and action
All are G-protein coupled receptors, which **except in α1** receptors either enhance or inhibit adenylate cyclase to raise or lower (respectively) cAMP and cause the cellular effect.


Sympathomimetics can be classified as **natural catecholamines**, **synthetic catecholamines**, or **"other"**.

##Adrenergic Agents
|              Properties              | Noradrenaline                                                                                                             | Adrenaline                                                                                                                | Dopamine                                                                                                                           | Phenylephrine                                           | Isoprenaline                                                                  | Dobutamine                                                               | Metaraminol               | 
|------------------|---------------------|---------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------|-------------------------------------------------------------------------------|--------------------------------------------------------------------------|---------------------------| 
|                    **Class**            | Natural Catecholamine                                                                                                     | Natural Catecholamine                                                                                                     | Natural Catecholamine                                                                                                              | Synthetic sympathomimetic                               | Synthetic Catecholamine                                                       | Synthetic Catecholamine                                                  | Synthetic amine           | 
|                  **Uses**               | ↑ SVR                                                                                                                     | Cardiac arrest, anaphylaxis, inotropy, chronotropy, adjunct in local anaesthetics                                         | Haemodynamic support                                                                                                               | ↑ SVR                                                   | Severe bradycardia                                                            | Stress testing, increasing CO                                            | ↑ SVR                     | 
|                    **Dosing**             | Start at 0.05µg/kg/min                                                                                                    | Infusion starts at: 0.01µg/kg/min                                                                                         | Start 1µg/kg/min                                                                                                                   | Bolus start at 50-100mcg                                | Infusion from 0.5-10µg/min                                                    | 0.5-20µg/kg/min                                                          | Bolus 0.5-2mg                   | 
| **Route**               | IV only                                                                                                                   | IV/IM/ETT/SC                                                                                                              | IV only                                                                                                                            | IV/IM/SC                                                | IV                                                                            | IV only                                                                  |           IV only                | 
|                  **Presentation**        | Clear, colourless solution                                                                                                | A clear, colourless solution typically at 0.1-1mg/ml                                                                      | Clear, colourless solution with 200mg or 800mg in water                                                                            | Clear, colourless solution at 100mcg/ml                 | Clear solution at 1mg/ml                                                      | 250mg dobutamine in 20ml water                                           |                           | 
|  **Absorption**          | IV only                                                                                                                   | Variable ETT and SC absorption                                                                                            | IV only                                                                                                                            | IM onset 15 minutes, duration up to 1 hour              |                                                                               |                                                                          |                           | 
|                 **Metabolism**          | t<sub>1/2</sub> 2min. Metabolised by mitochondrial MAO and COMT within liver, kidney, and blood to VMA and metadrenaline. | t<sub>1/2</sub> 2min. Metabolised by mitochondrial MAO and COMT within liver, kidney, and blood to VMA and metadrenaline. | t<sub>1/2</sub> 3 min. 25% of dose converted to noradrenaline. Remainder is metabolised by MAO and COMT similar to nor/adrenaline. | Hepatic by MAO                                          | Hepatic by COMT                                                               | t<sub>1/2</sub> 2 min. COMT to inactive metabolites.                     |                           | 
|                  **Elimination**         | Urinary excretion of metabolites                                                                                          | Urinary excretion of metabolites                                                                                          |                                                                                                                                    |                                                         | Urinary excetion of unchanged drug and metabolites                            | Urinary excretion of metabolites                                         |                           | 
| **Mechanism of action** | α>β                                                                                                                       |  β>α at lower doses                                                                                                       | D<sub>1</sub>, D<sub>2</sub>; β>α at lower doses                                                                                   | α1 only                                                 |                                                                               | β<sub>1</sub>>β<sub>2</sub>, D<sub>2</sub>                               | α1                        | 
|                  **Respiratory**        |                                                                                                                           | ↑ MV, bronchodilation                                                                                                     | ↓ response to hypoxaemia                                                                                                           |                                                         | Potent bronchodilation                                                        | Bronchodilation                                                          |                           | 
|                 **CVS**                | ↑SVR, ↑ Myocardial O<sub>2</sub> consumption, ↑Coronary flow.                                                             | Inotropy, ↑ HR, ↑ SVR, ↑ BP, ↑ myocardial O<sub>2</sub> consumption. Arrythmogenic.                                  |                                                                                                                                    | ↑ SVR, potential reflex bradycardia. Not arrythmogenic. | ↑ HR, CO, contractility, and automaticity. Β<sub>2</sub> effects may drop BP. | ↑ HR, ↑ inotropy, ↑ myocardial O<sub>2</sub> requirement. Arrythmogenic. | ↑ SVR, reflex bradycardia | 
|                 **CNS**                 |                                                                                                                           | ↑ Pain threshold, ↑MAC                                                                                                    | Inhibits prolactin.                                                                                                                |                                                         | Stimulant                                                                     | Tremor                                                                   |                           | 
|                 **MSK**    | Necrosis with extravasation                                                                                               | Necrosis with extravasation                                                                                               | Necrosis with extravasation                                                                                                        |                                                         |                                                                               |                                                                          |                           | 
|                 **Renal**               | ↓RBF                                                                                                                      | ↓RBF and ↑ in sphincter tone                                                                                              |                                                                                                                                    | ↓RBF                                                    |                                                                               | ↑ RBF and ↑ urinary output with no improvement in renal function         |                           | 
|                 **Metabolic**           |                                                                                                                           | ↑BMR, ↑ lipolysis, ↑gluconeogenesis and BSL, ↑lactate                                                                     |                                                                                                                                    |                                                         |                                                                               |                                                                          |                           | 
|                 **GU**             | ↓ Uterine blood flow and foetal bradycardia                                                                               |                                                                                                                           |                                                                                                                                    | ↓ Uterine blood flow                                    |                                                                               |                                                                          |                           | 


##References
Peck and Hill